Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Sacks

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
The Lancet. Microbe|June 19, 2023
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysisJelle Koopsen, Gail Matthews, Juergen Rockstroh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
The International Journal on Drug Policy|January 7, 2024
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019Maria-Bernarda Requena, Camelia Protopopescu, Ashleigh C Stewart, et al.
AIDS (London, England)|November 20, 2025
Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studiesKris Hage, Joanne Carson, Samira Hosseini-Hooshyar, et al.
Open Forum Infectious Diseases|April 1, 2024
Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Paul Agius, et al.
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
The Lancet. Public Health|March 25, 2023
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort studyCas J Isfordink, Anders Boyd, Rachel Sacks-Davis, et al.
The Journal of Infectious Diseases|April 18, 2015
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyRachel Sacks-Davis, Jason Grebely, Gregory J Dore, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 27, 2014
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
The Lancet. Microbe|June 19, 2023
Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysisJelle Koopsen, Gail Matthews, Juergen Rockstroh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009-2019Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, et al.
The International Journal on Drug Policy|March 29, 2022
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, et al.
The International Journal on Drug Policy|January 7, 2024
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019Maria-Bernarda Requena, Camelia Protopopescu, Ashleigh C Stewart, et al.
AIDS (London, England)|November 20, 2025
Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studiesKris Hage, Joanne Carson, Samira Hosseini-Hooshyar, et al.
Open Forum Infectious Diseases|April 1, 2024
Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020Brendan L Harney, Rachel Sacks-Davis, Paul Agius, et al.
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
The Lancet. Public Health|March 25, 2023
Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort studyCas J Isfordink, Anders Boyd, Rachel Sacks-Davis, et al.
The Journal of Infectious Diseases|April 18, 2015
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyRachel Sacks-Davis, Jason Grebely, Gregory J Dore, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 27, 2014
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Pageof 12